Hogbin Christopher reported grant involving 2,954 derivative units of Lazard, Inc. on Aug 14, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
CEO Asset Management
CEO Asset Management
Filed Aug 18, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
—Shares × reported price
Shares traded
2,954Restricted Stock Units
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
266,659Direct
Trade date
Aug 14, 2026Grant
Filed
Aug 18, 2026, 6:59 PM ET4-day reporting delay
Accession
0001628280-26-057801Code A · Transaction 5110
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

LAZ price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LAZ · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +2.2%1w ago +0.3%1d ago +3.2%
Returns since7d −1.4%30d −18%90d180d1y

Footnotes in full

F1: Additional Restricted Stock Units ("RSUs") were acquired pursuant to the dividend equivalent reinvestment provisions of underlying RSU awards. F2: Each RSU represents a contingent right to receive one share of Common Stock. F3: Of these RSUs, 985 will vest on or around March 18, 2027; 985 will vest on or around March 20, 2028; and 984 will vest on or around March 22, 2029. F4: Amount excludes 11,829 shares of Common Stock directly or indirectly beneficially owned by the reporting person.